New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Gossamer Bio, Inc.
GOSS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

297M

Biotechnology

Next Earning date - 04 Mar 2025

297M

Biotechnology

Next Earning date - 04 Mar 2025

1.31USD

0.00 ( 0.00%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

93
favorite-chart

Volume Buzz

36%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

18%

Quote Panel

Shape
Updated February 17, 2025
1W 5.65 % 1M 42.08 % 3M 81.92 % 1Y 3.97 %

Key Metrics

Shape
  • Market Cap

    296.85M


  • Shares Outstanding

    226.60M


  • Share in Float

    182.10M


  • Dividende

    0


  • Earning Date

    04 Mar 2025


  • Price Target

    1.31


  • Average Volume

    1.55M


  • Beta

    1.806


  • Range

    0.499-1.6


  • Industry

    Biotechnology


  • Website

    https://www.gossamerbio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

GOSS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$21M

Shape122%

2025-Revenue

$0.71

Shape-407%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Buy

2024-06-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2024-05-06

Now: Positive

Raymond James

downgrade

Previous: Outperform

2023-03-07

Now: Market Perform

Barclays

downgrade

Previous: Overweight

2022-12-07

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.59
vs -0.74

Q1.23

arrow
arrow

N/A

-0.52
vs -0.76

Q2.23

arrow
arrow

N/A

-0.45
vs -0.74

Q3.23

arrow
arrow

N/A

-0.21
vs -0.65

Q4.23

arrow
arrow

N/A

-0.21
vs -0.59

Q1.24

arrow
arrow

N/A

-0.19
vs -0.52

Q2.24

arrow
arrow

+149%

0.22
vs -0.45

Q3.24

arrow
arrow

N/A

-0.14
vs -0.21

Q4.24

arrow
arrow

N/A

-0.17
vs -0.21

Q1.25

arrow
arrow

N/A

-0.19
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

95.8M  vs NA

Q3.24

arrow
arrow

NA

9.5M  vs NA

Q4.24

arrow
arrow

+1%

6.8M  vs 6.8M

Q1.25

arrow
arrow

NA

3.6M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+6%

0.06
vs -1.11

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

+68%

0.68
vs 0.05

Q3.23

arrow
arrow

-38%

-0.38
vs 0.68

Q4.23

arrow
arrow

-77%

-0.77
vs -0.38

Q1.24

arrow
arrow

-157%

-1.57
vs -0.77

Q2.24

arrow
arrow

+60%

0.6
vs -1.57

Q3.24

arrow
arrow

-57%

-0.57
vs 0.6

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

113

113
vs 126

-10%

Q2.23

arrow
arrow

103

103
vs 113

-9%

Q3.23

arrow
arrow

98

98
vs 103

-5%

Q4.23

arrow
arrow

102

102
vs 98

4%

Q1.24

arrow
arrow

113

113
vs 102

11%

Q2.24

arrow
arrow

100

100
vs 113

-11%

Q3.24

arrow
arrow

107

107
vs 100

7%

Q4.24

arrow
arrow

108

108
vs 107

1%

Earnings Growth

Latest News